DeniseKarenReinkeNP

Denise Karen Reinke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

8 citations
Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.
Eugenie Younger, Karla V. Ballman, Yao Lu, Zsuzsanna Papai, Brian A. Van Tine
Journal of Geriatric Oncology. 2018-06-01
818 citations
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein Abdul-Hassan Tawbi, Melissa Amber Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze
The Lancet. Oncology. 2017-11-01
27 citations
Clinical trial enrollment of adolescents and young adults with sarcoma.
Lara E. Davis, Katherine A. Janeway, Aaron R. Weiss, Yen-Lin Chen, Thomas J. Scharschmidt
Cancer. 2017-09-15